{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:35:41Z","timestamp":1793136941193,"version":"4.5.0"},"reference-count":189,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T00:00:00Z","timestamp":1437523200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,7,22]],"date-time":"2015-07-22T00:00:00Z","timestamp":1437523200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["AR056099 and AR065778"],"award-info":[{"award-number":["AR056099 and AR065778"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PR093477"],"award-info":[{"award-number":["PR093477"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000980","name":"Arthritis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Angiogenesis"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10456-015-9477-2","type":"journal-article","created":{"date-parts":[[2015,7,21]],"date-time":"2015-07-21T15:09:53Z","timestamp":1437491393000},"page":"433-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":490,"title":["The pathogenic role of angiogenesis in rheumatoid arthritis"],"prefix":"10.1007","volume":"18","author":[{"given":"Hatem A.","family":"Elshabrawy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Volin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shalini","family":"Ravella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanti","family":"Virupannavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva","family":"Shahrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,22]]},"reference":[{"issue":"5","key":"9477_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/ar2515","volume":"10","author":"Z Szekanecz","year":"2008","unstructured":"Szekanecz Z, Koch AE (2008) Vascular involvement in rheumatic diseases: \u2018vascular rheumatology\u2019. Arthritis Res Ther 10(5):224","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"9477_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/ncprheum0647","volume":"3","author":"Z Szekanecz","year":"2007","unstructured":"Szekanecz Z, Koch AE (2007) Mechanisms of disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol 3(11):635\u2013643","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"4787","key":"9477_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1126\/science.2432664","volume":"235","author":"J Folkman","year":"1987","unstructured":"Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235(4787):442\u2013447","journal-title":"Science"},{"issue":"8","key":"9477_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/ncprheum0559","volume":"3","author":"D Lainer-Carr","year":"2007","unstructured":"Lainer-Carr D, Brahn E (2007) Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis. Nat Clin Pract Rheumatol 3(8):434\u2013442","journal-title":"Nat Clin Pract Rheumatol"},{"issue":"6","key":"9477_CR5","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1002\/1529-0131(199806)41:6<951::AID-ART2>3.0.CO;2-D","volume":"41","author":"AE Koch","year":"1998","unstructured":"Koch AE (1998) Angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum 41(6):951\u2013962","journal-title":"Arthritis Rheum"},{"issue":"5","key":"9477_CR6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.berh.2006.05.004","volume":"20","author":"DJ Veale","year":"2006","unstructured":"Veale DJ, Fearon U (2006) Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. Best Pract Res Clin Rheumatol 20(5):941\u2013947","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"3","key":"9477_CR7","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1097\/00002281-200105000-00009","volume":"13","author":"Z Szekanecz","year":"2001","unstructured":"Szekanecz Z, Koch AE (2001) Chemokines and angiogenesis. Curr Opin Rheumatol 13(3):202\u2013208","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"9477_CR8","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0163-7258(94)90027-2","volume":"63","author":"W Auerbach","year":"1994","unstructured":"Auerbach W, Auerbach R (1994) Angiogenesis inhibition: a review. Pharmacol Ther 63(3):265\u2013311","journal-title":"Pharmacol Ther"},{"issue":"Suppl 2","key":"9477_CR9","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar2187","volume":"9","author":"AE Koch","year":"2007","unstructured":"Koch AE, Distler O (2007) Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis. Arthritis Res Ther 9(Suppl 2):S3","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"9477_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/08916930903002461","volume":"42","author":"RA Chua","year":"2009","unstructured":"Chua RA, Arbiser JL (2009) The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity 42(7):574\u2013579","journal-title":"Autoimmunity"},{"issue":"10","key":"9477_CR11","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2174\/138161209787846892","volume":"15","author":"R Di Stefano","year":"2009","unstructured":"Di Stefano R, Felice F, Balbarini A (2009) Angiogenesis as risk factor for plaque vulnerability. Curr Pharm Des 15(10):1095\u20131106","journal-title":"Curr Pharm Des"},{"issue":"3","key":"9477_CR12","first-page":"231","volume":"20","author":"EJ Kushner","year":"2013","unstructured":"Kushner EJ, Bautch VL (2013) Building blood vessels in development and disease. Curr Opin Hematol 20(3):231\u2013236","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"9477_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.2174\/1568010054022187","volume":"4","author":"Z Szekanecz","year":"2005","unstructured":"Szekanecz Z, Koch AE (2005) Endothelial cells in inflammation and angiogenesis. Curr Drug Targets Inflamm Allergy 4(3):319\u2013323","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"9477_CR14","first-page":"821","volume-title":"Inflammation: basic principles and clinical correlates","author":"J Folkman","year":"1992","unstructured":"Folkman J, Brem H (1992) Angiogenesis and inflammation. In: Gallin JI, Goldstein IM, Snyderman R (eds) Inflammation: basic principles and clinical correlates, 2nd edn. Raven Press, New York, pp 821\u2013839","edition":"2"},{"key":"9477_CR15","first-page":"1","volume":"79","author":"J Folkman","year":"1997","unstructured":"Folkman J (1997) Angiogenesis and angiogenesis inhibition: an overview. EXS 79:1\u20138","journal-title":"EXS"},{"issue":"16","key":"9477_CR16","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","volume":"267","author":"J Folkman","year":"1992","unstructured":"Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267(16):10931\u201310934","journal-title":"J Biol Chem"},{"issue":"6","key":"9477_CR17","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1136\/ard.2004.029751","volume":"64","author":"JJ Haringman","year":"2005","unstructured":"Haringman JJ, Gerlag DM, Zwinderman AH, Smeets TJ, Kraan MC, Baeten D, McInnes IB, Bresnihan B, Tak PP (2005) Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Ann Rheum Dis 64(6):834\u2013838","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"9477_CR18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/00124743-199708000-00002","volume":"3","author":"PP Tak","year":"1997","unstructured":"Tak PP, Breedveld FC (1997) Analysis of serial synovial biopsies as a screening method for predicting the effects of therapeutic interventions. J Clin Rheumatol 3(4):186","journal-title":"J Clin Rheumatol"},{"issue":"12","key":"9477_CR19","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1002\/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V","volume":"43","author":"PP Tak","year":"2000","unstructured":"Tak PP, Bresnihan B (2000) The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum 43(12):2619\u20132633","journal-title":"Arthritis Rheum"},{"issue":"1","key":"9477_CR20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/art.1780390116","volume":"39","author":"D Mulherin","year":"1996","unstructured":"Mulherin D, Fitzgerald O, Bresnihan B (1996) Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum 39(1):115\u2013124","journal-title":"Arthritis Rheum"},{"issue":"11","key":"9477_CR21","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/art.1780391103","volume":"39","author":"GS Firestein","year":"1996","unstructured":"Firestein GS (1996) Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 39(11):1781\u20131790","journal-title":"Arthritis Rheum"},{"issue":"11","key":"9477_CR22","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ni.2419","volume":"13","author":"EL Gautier","year":"2012","unstructured":"Gautier EL, Shay T, Miller J, Greter M, Jakubzick C, Ivanov S, Helft J, Chow A, Elpek KG, Gordonov S, Mazloom AR, Ma\u2019ayan A, Chua WJ, Hansen TH, Turley SJ, Merad M, Randolph GJ (2012) Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat Immunol 13(11):1118\u20131128","journal-title":"Nat Immunol"},{"issue":"10","key":"9477_CR23","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/ni.2705","volume":"14","author":"LC Davies","year":"2013","unstructured":"Davies LC, Jenkins SJ, Allen JE, Taylor PR (2013) Tissue-resident macrophages. Nat Immunol 14(10):986\u2013995","journal-title":"Nat Immunol"},{"issue":"12","key":"9477_CR24","doi-asserted-by":"publisher","first-page":"3150","DOI":"10.1002\/eji.201242847","volume":"42","author":"S Tamoutounour","year":"2012","unstructured":"Tamoutounour S, Henri S, Lelouard H, de Bovis B, de Haar C, van der Woude CJ, Woltman AM, Reyal Y, Bonnet D, Sichien D, Bain CC, Mowat AM, Reis e Sousa C, Poulin LF, Malissen B, Guilliams M (2012) CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol 42(12):3150\u20133166","journal-title":"Eur J Immunol"},{"issue":"6077","key":"9477_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1126\/science.1219179","volume":"336","author":"C Schulz","year":"2012","unstructured":"Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, Jacobsen SE, Pollard JW, Frampton J, Liu KJ, Geissmann F (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336(6077):86\u201390","journal-title":"Science"},{"issue":"3","key":"9477_CR26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1038\/mi.2012.89","volume":"6","author":"CC Bain","year":"2013","unstructured":"Bain CC, Scott CL, Uronen-Hansson H, Gudjonsson S, Jansson O, Grip O, Guilliams M, Malissen B, Agace WW, Mowat AM (2013) Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 6(3):498\u2013510","journal-title":"Mucosal Immunol"},{"issue":"6","key":"9477_CR27","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/ni.2587","volume":"14","author":"V Jojic","year":"2013","unstructured":"Jojic V, Shay T, Sylvia K, Zuk O, Sun X, Kang J, Regev A, Koller D, Best AJ, Knell J, Goldrath A, Joic V, Cohen N, Brennan P, Brenner M, Kim F, Rao TN, Wagers A, Heng T, Ericson J, Rothamel K, Ortiz-Lopez A, Mathis D, Benoist C, Bezman NA, Sun JC, Min-Oo G, Kim CC, Lanier LL, Miller J, Brown B, Merad M, Gautier EL, Jakubzick C, Randolph GJ, Monach P, Blair DA, Dustin ML, Shinton SA, Hardy RR, Laidlaw D, Collins J, Gazit R, Rossi DJ, Malhotra N, Kreslavsky T, Fletcher A, Elpek K, Bellemarte-Pelletier A, Malhotra D, Turley S (2013) Identification of transcriptional regulators in the mouse immune system. Nat Immunol 14(6):633\u2013643","journal-title":"Nat Immunol"},{"issue":"1","key":"9477_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.immuni.2014.06.013","volume":"41","author":"S Epelman","year":"2014","unstructured":"Epelman S, Lavine KJ, Randolph GJ (2014) Origin and functions of tissue macrophages. Immunity 41(1):21\u201335","journal-title":"Immunity"},{"issue":"3","key":"9477_CR29","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.immuni.2013.08.007","volume":"39","author":"C Jakubzick","year":"2013","unstructured":"Jakubzick C, Gautier EL, Gibbings SL, Sojka DK, Schlitzer A, Johnson TE, Ivanov S, Duan Q, Bala S, Condon T, van Rooijen N, Grainger JR, Belkaid Y, Ma\u2019ayan A, Riches DW, Yokoyama WM, Ginhoux F, Henson PM, Randolph GJ (2013) Minimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodes. Immunity 39(3):599\u2013610","journal-title":"Immunity"},{"issue":"8","key":"9477_CR30","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.4049\/jimmunol.146.8.2719","volume":"146","author":"CD Mills","year":"1991","unstructured":"Mills CD (1991) Molecular basis of \u201csuppressor\u201d macrophages. Arginine metabolism via the nitric oxide synthetase pathway. J Immunol 146(8):2719\u20132723","journal-title":"J Immunol"},{"issue":"12","key":"9477_CR31","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12):677\u2013686","journal-title":"Trends Immunol"},{"issue":"3","key":"9477_CR32","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/ni.1990","volume":"12","author":"T Krausgruber","year":"2011","unstructured":"Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, Sahgal N, Hussell T, Feldmann M, Udalova IA (2011) IRF5 promotes inflammatory macrophage polarization and TH1\u2013TH17 responses. Nat Immunol 12(3):231\u2013238","journal-title":"Nat Immunol"},{"issue":"11","key":"9477_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549\u2013555","journal-title":"Trends Immunol"},{"issue":"3","key":"9477_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrrheum.2011.205","volume":"8","author":"S Konisti","year":"2012","unstructured":"Konisti S, Kiriakidis S, Paleolog EM (2012) Hypoxia\u2014a key regulator of angiogenesis and inflammation in rheumatoid arthritis. Nat Rev Rheumatol 8(3):153\u2013162","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"9477_CR35","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.molmed.2010.07.004","volume":"16","author":"E Neumann","year":"2010","unstructured":"Neumann E, Lefevre S, Zimmermann B, Gay S, Muller-Ladner U (2010) Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 16(10):458\u2013468","journal-title":"Trends Mol Med"},{"issue":"1","key":"9477_CR36","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS (2010) Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 233(1):233\u2013255","journal-title":"Immunol Rev"},{"issue":"Suppl 4","key":"9477_CR37","doi-asserted-by":"crossref","first-page":"iv52","DOI":"10.1136\/ard.2005.042424","volume":"64","author":"T Pap","year":"2005","unstructured":"Pap T, Meinecke I, Muller-Ladner U, Gay S (2005) Are fibroblasts involved in joint destruction? Ann Rheum Dis 64(Suppl 4):iv52\u2013iv54","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"9477_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/rheumatology\/kel065","volume":"45","author":"LC Huber","year":"2006","unstructured":"Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T (2006) Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology 45(6):669\u2013675","journal-title":"Rheumatology"},{"issue":"4","key":"9477_CR39","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.berh.2010.02.002","volume":"24","author":"M Niedermeier","year":"2010","unstructured":"Niedermeier M, Pap T, Korb A (2010) Therapeutic opportunities in fibroblasts in inflammatory arthritis. Best Pract Res Clin Rheumatol 24(4):527\u2013540","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"9477_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1084\/jem.180.1.341","volume":"180","author":"RA Fava","year":"1994","unstructured":"Fava RA, Olsen NJ, Spencer-Green G, Yeo KT, Yeo TK, Berse B, Jackman RW, Senger DR, Dvorak HF, Brown LF (1994) Vascular permeability factor\/endothelial growth factor (VPF\/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 180:341\u2013346","journal-title":"J Exp Med"},{"issue":"3","key":"9477_CR41","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/BOR.0b013e32805e87ae","volume":"19","author":"Z Szekanecz","year":"2007","unstructured":"Szekanecz Z, Koch AE (2007) Macrophages and their products in rheumatoid arthritis. Curr Opin Rheumatol 19(3):289\u2013295","journal-title":"Curr Opin Rheumatol"},{"issue":"8","key":"9477_CR42","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.4049\/jimmunol.152.8.4149","volume":"152","author":"AE Koch","year":"1994","unstructured":"Koch AE, Harlow LA, Haines GK, Amento EP, Unemori EN, Wong WL, Pope RM, Ferrara N (1994) Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 152(8):4149\u20134156","journal-title":"J Immunol"},{"issue":"6","key":"9477_CR43","first-page":"945","volume":"27","author":"E Brouwer","year":"2009","unstructured":"Brouwer E, Gouw AS, Posthumus MD, van Leeuwen MA, Boerboom AL, Bijzet J, Bos R, Limburg PC, Kallenberg CG, Westra J (2009) Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis. Clin Exp Rheumatol 27(6):945\u2013951","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"9477_CR44","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.autrev.2011.04.020","volume":"10","author":"A Marrelli","year":"2011","unstructured":"Marrelli A, Cipriani P, Liakouli V, Carubbi F, Perricone C, Perricone R, Giacomelli R (2011) Angiogenesis in rheumatoid arthritis: a disease specific process or a common response to chronic inflammation? Autoimmun Rev 10(10):595\u2013598","journal-title":"Autoimmun Rev"},{"issue":"5","key":"9477_CR45","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1136\/annrheumdis-2012-202444","volume":"73","author":"F Hu","year":"2014","unstructured":"Hu F, Mu R, Zhu J, Shi L, Li Y, Liu X, Shao W, Li G, Li M, Su Y, Cohen PL, Qiu X, Li Z (2014) Hypoxia and hypoxia-inducible factor-1alpha provoke toll-like receptor signalling-induced inflammation in rheumatoid arthritis. Ann Rheum Dis 73(5):928\u2013936","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"9477_CR46","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.4049\/jimmunol.164.11.5922","volume":"164","author":"J Lu","year":"2000","unstructured":"Lu J, Kasama T, Kobayashi K, Yoda Y, Shiozawa F, Hanyuda M, Negishi M, Ide H, Adachi M (2000) Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol 164(11):5922\u20135927","journal-title":"J Immunol"},{"issue":"5","key":"9477_CR47","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/S0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer T, Yamanishi Y, Clausen BE, Forster I, Pawlinski R, Mackman N, Haase VH, Jaenisch R, Corr M, Nizet V, Firestein GS, Gerber HP, Ferrara N, Johnson RS (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112(5):645\u2013657","journal-title":"Cell"},{"issue":"3","key":"9477_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/ar407","volume":"4","author":"S Shahrara","year":"2002","unstructured":"Shahrara S, Volin MV, Connors MA, Haines GK, Koch AE (2002) Differential expression of the angiogenic Tie receptor family in arthritic and normal synovial tissue. Arthritis Res 4(3):201\u2013208","journal-title":"Arthritis Res"},{"issue":"2","key":"9477_CR49","first-page":"260","volume":"30","author":"U Fearon","year":"2003","unstructured":"Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, Veale DJ (2003) Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 30(2):260\u2013268","journal-title":"J Rheumatol"},{"issue":"2","key":"9477_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1136\/ard.62.2.100","volume":"62","author":"EM Gravallese","year":"2003","unstructured":"Gravallese EM, Pettit AR, Lee R, Madore R, Manning C, Tsay A, Gaspar J, Goldring MB, Goldring SR, Oettgen P (2003) Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor alpha. Ann Rheum Dis 62(2):100\u2013107","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"9477_CR51","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1297-319X(03)00088-5","volume":"70","author":"G Clavel","year":"2003","unstructured":"Clavel G, Bessis N, Boissier MC (2003) Recent data on the role for angiogenesis in rheumatoid arthritis. Joint Bone Spine 70(5):321\u2013326","journal-title":"Joint Bone Spine"},{"issue":"1","key":"9477_CR52","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/0008-5472.CAN-12-2064","volume":"73","author":"C Daly","year":"2013","unstructured":"Daly C, Eichten A, Castanaro C, Pasnikowski E, Adler A, Lalani AS, Papadopoulos N, Kyle AH, Minchinton AI, Yancopoulos GD, Thurston G (2013) Angiopoietin-2 functions as a Tie2 agonist in tumor models, where it limits the effects of VEGF inhibition. Cancer Res 73(1):108\u2013118","journal-title":"Cancer Res"},{"issue":"5","key":"9477_CR53","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1002\/art.21016","volume":"52","author":"Y Chen","year":"2005","unstructured":"Chen Y, Donnelly E, Kobayashi H, Debusk LM, Lin PC (2005) Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. Arthritis Rheum 52(5):1585\u20131594","journal-title":"Arthritis Rheum"},{"issue":"4","key":"9477_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.joca.2005.10.004","volume":"14","author":"MC Honorati","year":"2006","unstructured":"Honorati MC, Neri S, Cattini L, Facchini A (2006) Interleukin-17, a regulator of angiogenic factor release by synovial fibroblasts. Osteoarthr Cartil 14(4):345\u2013352","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"9477_CR55","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/14397595.2014.900847","volume":"25","author":"H Shibuya","year":"2015","unstructured":"Shibuya H, Yoshitomi H, Murata K, Kobayashi S, Furu M, Ishikawa M, Fujii T, Ito H, Matsuda S (2015) TNFalpha, PDGF, and TGFbeta synergistically induce synovial lining hyperplasia via inducible PI3Kdelta. Mod Rheumatol 25(1):72\u201378","journal-title":"Mod Rheumatol"},{"issue":"4","key":"9477_CR56","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3109\/s10165-007-0592-9","volume":"17","author":"K Koyama","year":"2007","unstructured":"Koyama K, Hatsushika K, Ando T, Sakuma M, Wako M, Kato R, Haro H, Sugiyama H, Hamada Y, Ogawa H, Nakao A (2007) Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice. Mod Rheumatol 17(4):306\u2013310","journal-title":"Mod Rheumatol"},{"issue":"2","key":"9477_CR57","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/art.27186","volume":"62","author":"H Kokkonen","year":"2010","unstructured":"Kokkonen H, Soderstrom I, Rocklov J, Hallmans G, Lejon K, Rantapaa Dahlqvist S (2010) Up-regulation of cytokines and chemokines predates the onset of rheumatoid arthritis. Arthritis Rheum 62(2):383\u2013391","journal-title":"Arthritis Rheum"},{"issue":"6140","key":"9477_CR58","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/329630a0","volume":"329","author":"SJ Leibovich","year":"1987","unstructured":"Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V, Nuseir N (1987) Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329(6140):630\u2013632","journal-title":"Nature"},{"issue":"3","key":"9477_CR59","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00296-005-0619-5","volume":"26","author":"J Strunk","year":"2006","unstructured":"Strunk J, Bundke E, Lange U (2006) Anti-TNF-alpha antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor levels in patients with rheumatoid arthritis: a pilot study. Rheumatol Int 26(3):252\u2013256","journal-title":"Rheumatol Int"},{"issue":"6","key":"9477_CR60","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.jaad.2006.01.038","volume":"54","author":"T Markham","year":"2006","unstructured":"Markham T, Mullan R, Golden-Mason L, Rogers S, Bresnihan B, Fitzgerald O, Fearon U, Veale DJ (2006) Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy. J Am Acad Dermatol 54(6):1003\u20131012","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"9477_CR61","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00281-009-0189-9","volume":"32","author":"E Lubberts","year":"2010","unstructured":"Lubberts E (2010) Th17 cytokines and arthritis. Semin Immunopathol 32(1):43\u201353","journal-title":"Semin Immunopathol"},{"issue":"6","key":"9477_CR62","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.4049\/jimmunol.0903271","volume":"184","author":"SR Pickens","year":"2010","unstructured":"Pickens SR, Volin MV, Mandelin AM II, Kolls JK, Pope RM, Shahrara S (2010) IL-17 contributes to angiogenesis in rheumatoid arthritis. J Immunol 184(6):3233\u20133241","journal-title":"J Immunol"},{"issue":"4","key":"9477_CR63","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s10456-011-9227-z","volume":"14","author":"SR Pickens","year":"2011","unstructured":"Pickens SR, Chamberlain ND, Volin MV, Gonzalez M, Pope RM, Mandelin AM II, Kolls JK, Shahrara S (2011) Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization. Angiogen 14(4):443\u2013455","journal-title":"Angiogen"},{"issue":"4","key":"9477_CR64","doi-asserted-by":"publisher","first-page":"R126","DOI":"10.1186\/ar3431","volume":"13","author":"DY Chen","year":"2011","unstructured":"Chen DY, Chen YM, Chen HH, Hsieh CW, Lin CC, Lan JL (2011) Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-alpha therapy. Arthritis Res Ther 13(4):R126","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"9477_CR65","doi-asserted-by":"publisher","first-page":"R88","DOI":"10.1186\/ar3812","volume":"14","author":"Q Shu","year":"2012","unstructured":"Shu Q, Amin MA, Ruth JH, Campbell PL, Koch AE (2012) Suppression of endothelial cell activity by inhibition of TNFalpha. Arthritis Res Ther 14(2):R88","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"9477_CR66","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jbspin.2011.03.018","volume":"79","author":"JY Choe","year":"2012","unstructured":"Choe JY, Lee SJ, Park SH, Kim SK (2012) Tacrolimus (FK506) inhibits interleukin-1beta-induced angiopoietin-1, Tie-2 receptor, and vascular endothelial growth factor through down-regulation of JNK and p38 pathway in human rheumatoid fibroblast-like synoviocytes. Joint Bone Spine 79(2):137\u2013143","journal-title":"Joint Bone Spine"},{"issue":"4","key":"9477_CR67","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1002\/art.30232","volume":"63","author":"SR Pickens","year":"2011","unstructured":"Pickens SR, Chamberlain ND, Volin MV, Pope RM, Mandelin AM II, Shahrara S (2011) Characterization of CCL19 and CCL21 in rheumatoid arthritis. Arthritis Rheum 63(4):914\u2013922","journal-title":"Arthritis Rheum"},{"issue":"7","key":"9477_CR68","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1002\/art.37981","volume":"65","author":"T Isozaki","year":"2013","unstructured":"Isozaki T, Arbab AS, Haas CS, Amin MA, Arendt MD, Koch AE, Ruth JH (2013) Evidence that CXCL16 is a potent mediator of angiogenesis and is involved in endothelial progenitor cell chemotaxis: studies in mice with K\/BxN serum-induced arthritis. Arthritis Rheum 65(7):1736\u20131746","journal-title":"Arthritis Rheum"},{"issue":"10","key":"9477_CR69","doi-asserted-by":"publisher","first-page":"5986","DOI":"10.1073\/pnas.1035999100","volume":"100","author":"S Nakae","year":"2003","unstructured":"Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y (2003) IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci USA 100(10):5986\u20135990","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"9477_CR70","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/S0049-0172(96)80041-2","volume":"26","author":"R Badolato","year":"1996","unstructured":"Badolato R, Oppenheim JJ (1996) Role of cytokines, acute-phase proteins, and chemokines in the progression of rheumatoid arthritis. Semin Arthritis Rheum 26(2):526\u2013538","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 2","key":"9477_CR71","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/ar1917","volume":"8","author":"C Gabay","year":"2006","unstructured":"Gabay C (2006) Interleukin-6 and chronic inflammation. Arthritis Res Ther 8(Suppl 2):S3","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"9477_CR72","first-page":"213","volume":"12","author":"ML Blue","year":"1993","unstructured":"Blue ML, Conrad P, Webb DL, Sarr T, Macaro M (1993) Interacting monocytes and synoviocytes induce adhesion molecules by a cytokine-regulated process. Lymphokine Cytokine Res 12(4):213\u2013218","journal-title":"Lymphokine Cytokine Res"},{"issue":"6","key":"9477_CR73","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1002\/art.11143","volume":"48","author":"H Nakahara","year":"2003","unstructured":"Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N (2003) Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 48(6):1521\u20131529","journal-title":"Arthritis Rheum"},{"issue":"9","key":"9477_CR74","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/rheumatology\/kes093","volume":"51","author":"K Kayakabe","year":"2012","unstructured":"Kayakabe K, Kuroiwa T, Sakurai N, Ikeuchi H, Kadiombo AT, Sakairi T, Matsumoto T, Maeshima A, Hiromura K, Nojima Y (2012) Interleukin-6 promotes destabilized angiogenesis by modulating angiopoietin expression in rheumatoid arthritis. Rheumatology 51(9):1571\u20131579","journal-title":"Rheumatology"},{"issue":"Suppl 2","key":"9477_CR75","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1186\/1752-0509-6-S2-S12","volume":"6","author":"K Ogami","year":"2012","unstructured":"Ogami K, Yamaguchi R, Imoto S, Tamada Y, Araki H, Print C, Miyano S (2012) Computational gene network analysis reveals TNF-induced angiogenesis. BMC Syst Biol 6(Suppl 2):S12","journal-title":"BMC Syst Biol"},{"key":"9477_CR76","doi-asserted-by":"publisher","unstructured":"Chen Z, Kim SJ, Essani AB, Volin MV, Vila OM, Swedler W, Arami S, Volkov S, Sardin LV, Sweiss N, Shahrara S (2014) Characterising the expression and function of CCL28 and its corresponding receptor, CCR10, in RA pathogenesis. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-204530","DOI":"10.1136\/annrheumdis-2013-204530"},{"key":"9477_CR77","first-page":"349","volume":"8","author":"A Shetty","year":"2014","unstructured":"Shetty A, Hanson R, Korsten P, Shawagfeh M, Arami S, Volkov S, Vila O, Swedler W, Shunaigat AN, Smadi S, Sawaqed R, Perkins D, Shahrara S, Sweiss NJ (2014) Tocilizumab in the treatment of rheumatoid arthritis and beyond. Drug Des Dev Ther 8:349\u2013364","journal-title":"Drug Des Dev Ther"},{"issue":"7","key":"9477_CR78","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1002\/art.22707","volume":"56","author":"Q Huang","year":"2007","unstructured":"Huang Q, Ma Y, Adebayo A, Pope RM (2007) Increased macrophage activation mediated through toll-like receptors in rheumatoid arthritis. Arthritis Rheum 56(7):2192\u20132201","journal-title":"Arthritis Rheum"},{"issue":"7","key":"9477_CR79","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.4049\/jimmunol.147.7.2187","volume":"147","author":"AE Koch","year":"1991","unstructured":"Koch AE, Kunkel SL, Burrows JC, Evanoff HL, Haines GK, Pope RM, Strieter RM (1991) Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 147(7):2187\u20132195","journal-title":"J Immunol"},{"issue":"2","key":"9477_CR80","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.imlet.2006.11.005","volume":"108","author":"ML Cho","year":"2007","unstructured":"Cho ML, Ju JH, Kim HR, Oh HJ, Kang CM, Jhun JY, Lee SY, Park MK, Min JK, Park SH, Lee SH, Kim HY (2007) Toll-like receptor 2 ligand mediates the upregulation of angiogenic factor, vascular endothelial growth factor and interleukin-8\/CXCL8 in human rheumatoid synovial fibroblasts. Immunol Lett 108(2):121\u2013128","journal-title":"Immunol Lett"},{"issue":"5089","key":"9477_CR81","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1126\/science.1281554","volume":"258","author":"AE Koch","year":"1992","unstructured":"Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM (1992) Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258(5089):1798\u20131801","journal-title":"Science"},{"issue":"6","key":"9477_CR82","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1074\/jbc.M006814200","volume":"276","author":"VB Mehta","year":"2001","unstructured":"Mehta VB, Hart J, Wewers MD (2001) ATP-stimulated release of interleukin (IL)-1beta and IL-18 requires priming by lipopolysaccharide and is independent of caspase-1 cleavage. J Biol Chem 276(6):3820\u20133826","journal-title":"J Biol Chem"},{"issue":"10","key":"9477_CR83","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1172\/JCI7317","volume":"104","author":"JA Gracie","year":"1999","unstructured":"Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, Kennedy K, Carter R, Wei XQ, Xu D, Field M, Foulis A, Liew FY, McInnes IB (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104(10):1393\u20131401","journal-title":"J Clin Invest"},{"key":"9477_CR84","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/ar390","volume":"4","author":"B Moller","year":"2002","unstructured":"Moller B, Kessler U, Rehart S, Kalina U, Ottmann OG, Kaltwasser JP, Hoelzer D, Kukoc-Zivojnov N (2002) Expression of interleukin-18 receptor in fibroblast-like synoviocytes. Arthritis Res 4:139\u2013144","journal-title":"Arthritis Res"},{"issue":"12","key":"9477_CR85","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1002\/eji.200737488","volume":"37","author":"WA Verri Jr","year":"2007","unstructured":"Verri WA Jr, Cunha TM, Ferreira SH, Wei X, Leung BP, Fraser A, McInnes IB, Liew FY, Cunha FQ (2007) IL-15 mediates antigen-induced neutrophil migration by triggering IL-18 production. Eur J Immunol 37(12):3373\u20133380","journal-title":"Eur J Immunol"},{"issue":"3","key":"9477_CR86","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/art.27269","volume":"62","author":"H Marotte","year":"2010","unstructured":"Marotte H, Ahmed S, Ruth JH, Koch AE (2010) Blocking ERK-1\/2 reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity in rheumatoid arthritis synovial fibroblasts by induction of interleukin-18 binding protein A. Arthritis Rheum 62(3):722\u2013731","journal-title":"Arthritis Rheum"},{"issue":"10","key":"9477_CR87","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1089\/jir.2011.0050","volume":"31","author":"MV Volin","year":"2011","unstructured":"Volin MV, Koch AE (2011) Interleukin-18: a mediator of inflammation and angiogenesis in rheumatoid arthritis. J Interferon Cytokine Res 31(10):745\u2013751","journal-title":"J Interferon Cytokine Res"},{"issue":"2","key":"9477_CR88","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.4049\/jimmunol.171.2.1009","volume":"171","author":"CA Canetti","year":"2003","unstructured":"Canetti CA, Leung BP, Culshaw S, McInnes IB, Cunha FQ, Liew FY (2003) IL-18 enhances collagen-induced arthritis by recruiting neutrophils via TNF-alpha and leukotriene B4. J Immunol 171(2):1009\u20131015","journal-title":"J Immunol"},{"issue":"3","key":"9477_CR89","doi-asserted-by":"publisher","first-page":"R118","DOI":"10.1186\/ar3055","volume":"12","author":"JH Ruth","year":"2010","unstructured":"Ruth JH, Park CC, Amin MA, Lesch C, Marotte H, Shahrara S, Koch AE (2010) Interleukin-18 as an in vivo mediator of monocyte recruitment in rodent models of rheumatoid arthritis. Arthritis Res Ther 12(3):R118","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"9477_CR90","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1136\/ard.2009.127241","volume":"69","author":"MA Amin","year":"2010","unstructured":"Amin MA, Rabquer BJ, Mansfield PJ, Ruth JH, Marotte H, Haas CS, Reamer EN, Koch AE (2010) Interleukin 18 induces angiogenesis in vitro and in vivo via Src and Jnk kinases. Ann Rheum Dis 69(12):2204\u20132212","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"9477_CR91","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.4049\/jimmunol.167.3.1644","volume":"167","author":"CC Park","year":"2001","unstructured":"Park CC, Morel JC, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Evidence of IL-18 as a novel angiogenic mediator. J Immunol 167(3):1644\u20131653","journal-title":"J Immunol"},{"issue":"6","key":"9477_CR92","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1002\/art.22705","volume":"56","author":"MA Amin","year":"2007","unstructured":"Amin MA, Mansfield PJ, Pakozdi A, Campbell PL, Ahmed S, Martinez RJ, Koch AE (2007) Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways. Arthritis Rheum 56(6):1787\u20131797","journal-title":"Arthritis Rheum"},{"issue":"10","key":"9477_CR93","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/labinvest.3780351","volume":"81","author":"JC Morel","year":"2001","unstructured":"Morel JC, Park CC, Kumar P, Koch AE (2001) Interleukin-18 induces rheumatoid arthritis synovial fibroblast CXC chemokine production through NFkappaB activation. Lab Invest 81(10):1371\u20131383","journal-title":"Lab Invest"},{"issue":"12","key":"9477_CR94","doi-asserted-by":"publisher","first-page":"8280","DOI":"10.4049\/jimmunol.175.12.8280","volume":"175","author":"JK Yoo","year":"2005","unstructured":"Yoo JK, Kwon H, Khil LY, Zhang L, Jun HS, Yoon JW (2005) IL-18 induces monocyte chemotactic protein-1 production in macrophages through the phosphatidylinositol 3-kinase\/Akt and MEK\/ERK1\/2 pathways. J Immunol 175(12):8280\u20138286","journal-title":"J Immunol"},{"issue":"2","key":"9477_CR95","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1006\/cyto.1998.0402","volume":"11","author":"S Onodera","year":"1999","unstructured":"Onodera S, Tanji H, Suzuki K, Kaneda K, Mizue Y, Sagawa A, Nishihira J (1999) High expression of macrophage migration inhibitory factor in the synovial tissues of rheumatoid joints. Cytokine 11(2):163\u2013167","journal-title":"Cytokine"},{"issue":"8","key":"9477_CR96","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/1529-0131(199908)42:8<1601::AID-ANR6>3.0.CO;2-B","volume":"42","author":"M Leech","year":"1999","unstructured":"Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF (1999) Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42(8):1601\u20131608","journal-title":"Arthritis Rheum"},{"issue":"6","key":"9477_CR97","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1084\/jem.179.6.1895","volume":"179","author":"T Calandra","year":"1994","unstructured":"Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179(6):1895\u20131902","journal-title":"J Exp Med"},{"issue":"6544","key":"9477_CR98","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/377068a0","volume":"377","author":"T Calandra","year":"1995","unstructured":"Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377(6544):68\u201371","journal-title":"Nature"},{"issue":"3","key":"9477_CR99","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/nm0397-320","volume":"3","author":"SC Donnelly","year":"1997","unstructured":"Donnelly SC, Haslett C, Reid PT, Grant IS, Wallace WA, Metz CN, Bruce LJ, Bucala R (1997) Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat Med 3(3):320\u2013323","journal-title":"Nat Med"},{"issue":"1","key":"9477_CR100","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1074\/jbc.275.1.444","volume":"275","author":"S Onodera","year":"2000","unstructured":"Onodera S, Kaneda K, Mizue Y, Koyama Y, Fujinaga M, Nishihira J (2000) Macrophage migration inhibitory factor up-regulates expression of matrix metalloproteinases in synovial fibroblasts of rheumatoid arthritis. J Biol Chem 275(1):444\u2013450","journal-title":"J Biol Chem"},{"issue":"5","key":"9477_CR101","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/art.20190","volume":"50","author":"S Onodera","year":"2004","unstructured":"Onodera S, Nishihira J, Koyama Y, Majima T, Aoki Y, Ichiyama H, Ishibashi T, Minami A (2004) Macrophage migration inhibitory factor up-regulates the expression of interleukin-8 messenger RNA in synovial fibroblasts of rheumatoid arthritis patients: common transcriptional regulatory mechanism between interleukin-8 and interleukin-1beta. Arthritis Rheum 50(5):1437\u20131447","journal-title":"Arthritis Rheum"},{"issue":"4","key":"9477_CR102","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/01.RES.0000087641.56024.DA","volume":"93","author":"MA Amin","year":"2003","unstructured":"Amin MA, Volpert OV, Woods JM, Kumar P, Harlow LA, Koch AE (2003) Migration inhibitory factor mediates angiogenesis via mitogen-activated protein kinase and phosphatidylinositol kinase. Circ Res 93(4):321\u2013329","journal-title":"Circ Res"},{"issue":"3","key":"9477_CR103","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/cyto.1997.0276","volume":"10","author":"J Nishihira","year":"1998","unstructured":"Nishihira J, Koyama Y, Mizue Y (1998) Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10(3):199\u2013205","journal-title":"Cytokine"},{"issue":"4","key":"9477_CR104","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1006\/cyto.1999.0562","volume":"12","author":"H Ogawa","year":"2000","unstructured":"Ogawa H, Nishihira J, Sato Y, Kondo M, Takahashi N, Oshima T, Todo S (2000) An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 12(4):309\u2013314","journal-title":"Cytokine"},{"issue":"5","key":"9477_CR105","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/1529-0131(199805)41:5<910::AID-ART19>3.0.CO;2-E","volume":"41","author":"M Leech","year":"1998","unstructured":"Leech M, Metz C, Santos L, Peng T, Holdsworth SR, Bucala R, Morand EF (1998) Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 41(5):910\u2013917","journal-title":"Arthritis Rheum"},{"issue":"2","key":"9477_CR106","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/j.1365-2249.2008.03639.x","volume":"152","author":"LL Santos","year":"2008","unstructured":"Santos LL, Dacumos A, Yamana J, Sharma L, Morand EF (2008) Reduced arthritis in MIF deficient mice is associated with reduced T cell activation: down-regulation of ERK MAP kinase phosphorylation. Clin Exp Immunol 152(2):372\u2013380","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"9477_CR107","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s00296-013-2713-4","volume":"33","author":"A Singh","year":"2013","unstructured":"Singh A, Leng L, Fan J, Gajda M, Brauer R, Fingerle-Rowson G, Bucala R, Illges H (2013) Macrophage-derived, macrophage migration inhibitory factor (MIF) is necessary to induce disease in the K\/BxN serum-induced model of arthritis. Rheumatol Int 33(9):2301\u20132308","journal-title":"Rheumatol Int"},{"key":"9477_CR108","doi-asserted-by":"publisher","first-page":"153","DOI":"10.2741\/s53","volume":"2","author":"Z Szekanecz","year":"2010","unstructured":"Szekanecz Z, Vegvari A, Szabo Z, Koch AE (2010) Chemokines and chemokine receptors in arthritis. Front Biosci (Schol Ed) 2:153\u2013167","journal-title":"Front Biosci (Schol Ed)"},{"issue":"5","key":"9477_CR109","first-page":"581","volume":"22","author":"N Maruotti","year":"2007","unstructured":"Maruotti N, Cantatore FP, Crivellato E, Vacca A, Ribatti D (2007) Macrophages in rheumatoid arthritis. Histol Histopathol 22(5):581\u2013586","journal-title":"Histol Histopathol"},{"issue":"2","key":"9477_CR110","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1097\/BOR.0000000000000150","volume":"27","author":"DL Asquith","year":"2015","unstructured":"Asquith DL, Bryce SA, Nibbs RJ (2015) Targeting cell migration in rheumatoid arthritis. Curr Opin Rheumatol 27(2):204\u2013211","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"9477_CR111","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1002\/art.38352","volume":"66","author":"YJ Park","year":"2014","unstructured":"Park YJ, Kim JY, Park J, Choi JJ, Kim WU, Cho CS (2014) Bone erosion is associated with reduction of circulating endothelial progenitor cells and endothelial dysfunction in rheumatoid arthritis. Arthritis Rheumatol 66(6):1450\u20131460","journal-title":"Arthritis Rheumatol"},{"issue":"17","key":"9477_CR112","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.3760\/cma.j.issn.0366-6999.20130748","volume":"126","author":"PF Wu","year":"2013","unstructured":"Wu PF, Lu ZP, Cai BB, Tian L, Zou C, Jiang KR, Miao Y (2013) Role of CXCL12\/CXCR4 signaling axis in pancreatic cancer. Chin Med J 126(17):3371\u20133374","journal-title":"Chin Med J"},{"issue":"5","key":"9477_CR113","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3892\/ol.2014.1926","volume":"7","author":"H Wang","year":"2014","unstructured":"Wang H, Liu W, Wei D, Hu K, Wu X, Yao Y (2014) Effect of the LPA-mediated CXCL12\u2013CXCR4 axis in the tumor proliferation, migration and invasion of ovarian cancer cell lines. Oncol Lett 7(5):1581\u20131585","journal-title":"Oncol Lett"},{"issue":"4","key":"9477_CR114","first-page":"340","volume":"6","author":"I Ghanem","year":"2014","unstructured":"Ghanem I, Riveiro ME, Paradis V, Faivre S, de Parga PM, Raymond E (2014) Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis. Am J Transl Res 6(4):340\u2013352","journal-title":"Am J Transl Res"},{"issue":"9","key":"9477_CR115","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1517\/14728222.2014.930440","volume":"18","author":"A Villalvilla","year":"2014","unstructured":"Villalvilla A, Gomez R, Roman-Blas JA, Largo R, Herrero-Beaumont G (2014) SDF-1 signaling: a promising target in rheumatic diseases. Expert Opin Ther Targets 18(9):1077\u20131087","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"9477_CR116","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.4049\/jimmunol.170.4.2147","volume":"170","author":"JL Pablos","year":"2003","unstructured":"Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ, Garcia-Lazaro FJ (2003) Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 170(4):2147\u20132152","journal-title":"J Immunol"},{"issue":"6685","key":"9477_CR117","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/31261","volume":"393","author":"K Tachibana","year":"1998","unstructured":"Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, Nagasawa T (1998) The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 393(6685):591\u2013594","journal-title":"Nature"},{"issue":"3","key":"9477_CR118","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/art.10102","volume":"46","author":"MC Blades","year":"2002","unstructured":"Blades MC, Ingegnoli F, Wheller SK, Manzo A, Wahid S, Panayi GS, Perretti M, Pitzalis C (2002) Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID mice. Arthritis Rheum 46(3):824\u2013836","journal-title":"Arthritis Rheum"},{"issue":"5","key":"9477_CR119","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.4049\/jimmunol.180.5.3467","volume":"180","author":"LA Madge","year":"2008","unstructured":"Madge LA, Kluger MS, Orange JS, May MJ (2008) Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells. J Immunol 180(5):3467\u20133477","journal-title":"J Immunol"},{"issue":"3","key":"9477_CR120","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/path.4403","volume":"234","author":"AR Noort","year":"2014","unstructured":"Noort AR, van Zoest KP, Weijers EM, Koolwijk P, Maracle CX, Novack DV, Siemerink MJ, Schlingemann RO, Tak PP, Tas SW (2014) NF-kappaB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis. J Pathol 234(3):375\u2013385","journal-title":"J Pathol"},{"issue":"4","key":"9477_CR121","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/S0002-9440(10)65365-5","volume":"154","author":"R Salcedo","year":"1999","unstructured":"Salcedo R, Wasserman K, Young HA, Grimm MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ, Oppenheim JJ (1999) Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154(4):1125\u20131135","journal-title":"Am J Pathol"},{"issue":"1","key":"9477_CR122","first-page":"102","volume":"6","author":"SA Rempel","year":"2000","unstructured":"Rempel SA, Dudas S, Ge S, Gutierrez JA (2000) Identification and localization of the cytokine SDF1 and its receptor, CXC chemokine receptor 4, to regions of necrosis and angiogenesis in human glioblastoma. Clin Cancer Res 6(1):102\u2013111","journal-title":"Clin Cancer Res"},{"issue":"9","key":"9477_CR123","first-page":"3530","volume":"6","author":"T Koshiba","year":"2000","unstructured":"Koshiba T, Hosotani R, Miyamoto Y, Ida J, Tsuji S, Nakajima S, Kawaguchi M, Kobayashi H, Doi R, Hori T, Fujii N, Imamura M (2000) Expression of stromal cell-derived factor 1 and CXCR4 ligand receptor system in pancreatic cancer: a possible role for tumor progression. Clin Cancer Res 6(9):3530\u20133535","journal-title":"Clin Cancer Res"},{"issue":"8","key":"9477_CR124","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.4049\/jimmunol.167.8.4686","volume":"167","author":"P Matthys","year":"2001","unstructured":"Matthys P, Hatse S, Vermeire K, Wuyts A, Bridger G, Henson GW, De Clercq E, Billiau A, Schols D (2001) AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. J Immunol 167(8):4686\u20134692","journal-title":"J Immunol"},{"issue":"3","key":"9477_CR125","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/art.21662","volume":"54","author":"JH Ruth","year":"2006","unstructured":"Ruth JH, Haas CS, Park CC, Amin MA, Martinez RJ, Haines GK III, Shahrara S, Campbell PL, Koch AE (2006) CXCL16-mediated cell recruitment to rheumatoid arthritis synovial tissue and murine lymph nodes is dependent upon the MAPK pathway. Arthritis Rheum 54(3):765\u2013778","journal-title":"Arthritis Rheum"},{"issue":"5","key":"9477_CR126","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1002\/1529-0131(200105)44:5<1022::AID-ANR181>3.0.CO;2-N","volume":"44","author":"KJ Katschke Jr","year":"2001","unstructured":"Katschke KJ Jr, Rottman JB, Ruth JH, Qin S, Wu L, LaRosa G, Ponath P, Park CC, Pope RM, Koch AE (2001) Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes\/macrophages in rheumatoid arthritis. Arthritis Rheum 44(5):1022\u20131032","journal-title":"Arthritis Rheum"},{"issue":"12","key":"9477_CR127","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1002\/1529-0131(200112)44:12<2750::AID-ART462>3.0.CO;2-C","volume":"44","author":"JH Ruth","year":"2001","unstructured":"Ruth JH, Rottman JB, Katschke KJ Jr, Qin S, Wu L, LaRosa G, Ponath P, Pope RM, Koch AE (2001) Selective lymphocyte chemokine receptor expression in the rheumatoid joint. Arthritis Rheum 44(12):2750\u20132760","journal-title":"Arthritis Rheum"},{"issue":"12","key":"9477_CR128","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1002\/art.11344","volume":"48","author":"S Shahrara","year":"2003","unstructured":"Shahrara S, Amin MA, Woods JM, Haines GK, Koch AE (2003) Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis. Arthritis Rheum 48(12):3568\u20133583","journal-title":"Arthritis Rheum"},{"issue":"6","key":"9477_CR129","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1002\/art.21033","volume":"52","author":"S Shahrara","year":"2005","unstructured":"Shahrara S, Proudfoot AE, Woods JM, Ruth JH, Amin MA, Park CC, Haas CS, Pope RM, Haines GK, Zha YY, Koch AE (2005) Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis Rheum 52(6):1907\u20131919","journal-title":"Arthritis Rheum"},{"issue":"5","key":"9477_CR130","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.4049\/jimmunol.180.5.3447","volume":"180","author":"S Shahrara","year":"2008","unstructured":"Shahrara S, Proudfoot AE, Park CC, Volin MV, Haines GK, Woods JM, Aikens CH, Handel TM, Pope RM (2008) Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis. J Immunol 180(5):3447\u20133456","journal-title":"J Immunol"},{"issue":"8","key":"9477_CR131","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1002\/art.34452","volume":"64","author":"SR Pickens","year":"2012","unstructured":"Pickens SR, Chamberlain ND, Volin MV, Pope RM, Talarico NE, Mandelin AM II, Shahrara S (2012) Role of the CCL21 and CCR7 pathways in rheumatoid arthritis angiogenesis. Arthritis Rheum 64(8):2471\u20132481","journal-title":"Arthritis Rheum"},{"issue":"7","key":"9477_CR132","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1002\/1529-0131(200107)44:7<1568::AID-ART280>3.0.CO;2-1","volume":"44","author":"JH Ruth","year":"2001","unstructured":"Ruth JH, Volin MV, Haines GK III, Woodruff DC, Katschke KJ Jr, Woods JM, Park CC, Morel JC, Koch AE (2001) Fractalkine, a novel chemokine in rheumatoid arthritis and in rat adjuvant-induced arthritis. Arthritis Rheum 44(7):1568\u20131581","journal-title":"Arthritis Rheum"},{"issue":"4","key":"9477_CR133","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jlb.67.4.577","volume":"67","author":"GE Garcia","year":"2000","unstructured":"Garcia GE, Xia Y, Chen S, Wang Y, Ye RD, Harrison JK, Bacon KB, Zerwes HG, Feng L (2000) NF-kappaB-dependent fractalkine induction in rat aortic endothelial cells stimulated by IL-1beta, TNF-alpha, and LPS. J Leukoc Biol 67(4):577\u2013584","journal-title":"J Leukoc Biol"},{"issue":"2","key":"9477_CR134","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1620\/tjem.192.127","volume":"192","author":"T Imaizumi","year":"2000","unstructured":"Imaizumi T, Matsumiya T, Fujimoto K, Okamoto K, Cui X, Ohtaki U, Hidemi Yoshida, Satoh K (2000) Interferon-gamma stimulates the expression of CX3CL1\/fractalkine in cultured human endothelial cells. Tohoku J Exp Med 192(2):127\u2013139","journal-title":"Tohoku J Exp Med"},{"issue":"4","key":"9477_CR135","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/S0002-9440(10)62537-0","volume":"159","author":"MV Volin","year":"2001","unstructured":"Volin MV, Woods JM, Amin MA, Connors MA, Harlow LA, Koch AE (2001) Fractalkine: a novel angiogenic chemokine in rheumatoid arthritis. Am J Pathol 159(4):1521\u20131530","journal-title":"Am J Pathol"},{"issue":"Suppl 3","key":"9477_CR136","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1186\/ar572","volume":"4","author":"G Murphy","year":"2002","unstructured":"Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I (2002) Matrix metalloproteinases in arthritic disease. Arthritis Res 4(Suppl 3):S39\u2013S49","journal-title":"Arthritis Res"},{"issue":"6","key":"9477_CR137","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/1529-0131(200006)43:6<1226::AID-ANR5>3.0.CO;2-4","volume":"43","author":"T Pap","year":"2000","unstructured":"Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, Billingham M, Gay S (2000) Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum 43(6):1226\u20131232","journal-title":"Arthritis Rheum"},{"issue":"9","key":"9477_CR138","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1002\/art.1780390919","volume":"39","author":"D Ahrens","year":"1996","unstructured":"Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ (1996) Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum 39(9):1576\u20131587","journal-title":"Arthritis Rheum"},{"issue":"9","key":"9477_CR139","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1136\/ard.56.9.542","volume":"56","author":"AJ Freemont","year":"1997","unstructured":"Freemont AJ, Hampson V, Tilman R, Goupille P, Taiwo Y, Hoyland JA (1997) Gene expression of matrix metalloproteinases 1, 3, and 9 by chondrocytes in osteoarthritic human knee articular cartilage is zone and grade specific. Ann Rheum Dis 56(9):542\u2013549","journal-title":"Ann Rheum Dis"},{"key":"9477_CR140","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/ar401","volume":"4","author":"MP Vincenti","year":"2002","unstructured":"Vincenti MP, Brinckerhoff CE (2002) Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res 4:157\u2013164","journal-title":"Arthritis Res"},{"issue":"3","key":"9477_CR141","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrm763","volume":"3","author":"CE Brinckerhoff","year":"2002","unstructured":"Brinckerhoff CE, Matrisian LM (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nat Rev Mol Cell Biol 3(3):207\u2013214","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"9477_CR142","doi-asserted-by":"publisher","first-page":"R64","DOI":"10.1186\/ar2689","volume":"11","author":"MA Akhavani","year":"2009","unstructured":"Akhavani MA, Madden L, Buysschaert I, Sivakumar B, Kang N, Paleolog EM (2009) Hypoxia upregulates angiogenesis and synovial cell migration in rheumatoid arthritis. Arthritis Res Ther 11(3):R64","journal-title":"Arthritis Res Ther"},{"key":"9477_CR143","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2741\/1817","volume":"11","author":"PS Burrage","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE (2006) Matrix metalloproteinases: role in arthritis. Front Biosci 11:529\u2013543","journal-title":"Front Biosci"},{"issue":"4","key":"9477_CR144","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00296-010-1592-1","volume":"31","author":"KS Kim","year":"2011","unstructured":"Kim KS, Choi HM, Lee YA, Choi IA, Lee SH, Hong SJ, Yang HI, Yoo MC (2011) Expression levels and association of gelatinases MMP-2 and MMP-9 and collagenases MMP-1 and MMP-13 with VEGF in synovial fluid of patients with arthritis. Rheumatol Int 31(4):543\u2013547","journal-title":"Rheumatol Int"},{"issue":"1","key":"9477_CR145","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/1529-0131(200201)46:1<13::AID-ART497>3.0.CO;2-S","volume":"46","author":"JA Mengshol","year":"2002","unstructured":"Mengshol JA, Mix KS, Brinckerhoff CE (2002) Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull\u2019s-eye or missing the mark? Arthritis Rheum 46(1):13\u201320","journal-title":"Arthritis Rheum"},{"issue":"10","key":"9477_CR146","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1002\/art.23867","volume":"58","author":"BJ Rabquer","year":"2008","unstructured":"Rabquer BJ, Pakozdi A, Michel JE, Gujar BS, Haines GK III, Imhof BA, Koch AE (2008) Junctional adhesion molecule C mediates leukocyte adhesion to rheumatoid arthritis synovium. Arthritis Rheum 58(10):3020\u20133029","journal-title":"Arthritis Rheum"},{"issue":"3","key":"9477_CR147","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.4049\/jimmunol.1000556","volume":"185","author":"BJ Rabquer","year":"2010","unstructured":"Rabquer BJ, Amin MA, Teegala N, Shaheen MK, Tsou PS, Ruth JH, Lesch CA, Imhof BA, Koch AE (2010) Junctional adhesion molecule-C is a soluble mediator of angiogenesis. J Immunol 185(3):1777\u20131785","journal-title":"J Immunol"},{"issue":"4","key":"9477_CR148","doi-asserted-by":"publisher","first-page":"R65","DOI":"10.1186\/ar2223","volume":"9","author":"G Palmer","year":"2007","unstructured":"Palmer G, Busso N, Aurrand-Lions M, Talabot-Ayer D, Chobaz-Peclat V, Zimmerli C, Hammel P, Imhof BA, Gabay C (2007) Expression and function of junctional adhesion molecule-C in human and experimental arthritis. Arthritis Res Ther 9(4):R65","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"9477_CR149","doi-asserted-by":"publisher","first-page":"4244","DOI":"10.1096\/fj.13-230441","volume":"27","author":"DA Leinster","year":"2013","unstructured":"Leinster DA, Colom B, Whiteford JR, Ennis DP, Lockley M, McNeish IA, Aurrand-Lions M, Chavakis T, Imhof BA, Balkwill FR, Nourshargh S (2013) Endothelial cell junctional adhesion molecule C plays a key role in the development of tumors in a murine model of ovarian cancer. FASEB J 27(10):4244\u20134253","journal-title":"FASEB J"},{"issue":"6","key":"9477_CR150","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.1780400602","volume":"40","author":"CF Mojcik","year":"1997","unstructured":"Mojcik CF, Shevach EM (1997) Adhesion molecules: a rheumatologic perspective. Arthritis Rheum 40(6):991\u20131004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"9477_CR151","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0049-0172(96)80034-5","volume":"25","author":"RW McMurray","year":"1996","unstructured":"McMurray RW (1996) Adhesion molecules in autoimmune disease. Semin Arthritis Rheum 25(4):215\u2013233","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"9477_CR152","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1006\/clin.1996.0039","volume":"78","author":"S Hosaka","year":"1996","unstructured":"Hosaka S, Shah MR, Pope RM, Koch AE (1996) Soluble forms of P-selectin and intercellular adhesion molecule-3 in synovial fluids. Clin Immunol Immunopathol 78(3):276\u2013282","journal-title":"Clin Immunol Immunopathol"},{"key":"9477_CR153","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1006\/clin.1994.1074","volume":"71","author":"AE Koch","year":"1994","unstructured":"Koch AE, Shah MR, Harlow LA, Lovis RM, Pope RM (1994) Soluble intercellular adhesion molecule-1 in arthritis. Clin Immunol Immunopathol 71:208\u2013215","journal-title":"Clin Immunol Immunopathol"},{"issue":"6540","key":"9477_CR154","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/376517a0","volume":"376","author":"AE Koch","year":"1995","unstructured":"Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995) Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 376(6540):517\u2013519","journal-title":"Nature"},{"key":"9477_CR155","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.4049\/jimmunol.159.8.4103","volume":"159","author":"RC Schimmer","year":"1997","unstructured":"Schimmer RC, Schrier DJ, Flory CM, Dykens J, Tung DK, Jacobson PB, Friedl HP, Conroy MC, Schimmer BB, Ward PA (1997) Streptococcal cell wall-induced arthritis: requirements for neutrophils, P-selectin, intercellular adhesion molecule-1, and macrophage-inflammatory protein-2. J Immunol 159:4103\u20134108","journal-title":"J Immunol"},{"issue":"2","key":"9477_CR156","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/0008-8749(92)90294-Y","volume":"142","author":"K Kakimoto","year":"1992","unstructured":"Kakimoto K, Nakamura T, Ishii K, Takashi T, Iigou H, Yagita H, Okumura K, Onoue K (1992) The effect of anti-adhesion molecule antibody on the development of collagen-induced arthritis. Cell Immunol 142(2):326\u2013337","journal-title":"Cell Immunol"},{"issue":"9","key":"9477_CR157","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/ard.61.9.804","volume":"61","author":"PA Klimiuk","year":"2002","unstructured":"Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik JP, Cylwik B, Skowronski J, Chwiecko J (2002) Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis 61(9):804\u2013809","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"9477_CR158","doi-asserted-by":"publisher","first-page":"R93","DOI":"10.1186\/ar2477","volume":"10","author":"S Shahrara","year":"2008","unstructured":"Shahrara S, Huang Q, Mandelin AM II, Pope RM (2008) TH-17 cells in rheumatoid arthritis. Arthritis Res Ther 10(4):R93","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"9477_CR159","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1002\/art.37992","volume":"65","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Chen Z, Chamberlain ND, Volin MV, Swedler W, Volkov S, Sweiss N, Shahrara S (2013) Angiogenesis in rheumatoid arthritis is fostered directly by Toll-like receptor 5 ligation and indirectly through interleukin-17 induction. Arthritis Rheum 65(8):2024\u20132036","journal-title":"Arthritis Rheum"},{"issue":"8","key":"9477_CR160","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.1002\/art.30324","volume":"63","author":"SR Pickens","year":"2011","unstructured":"Pickens SR, Chamberlain ND, Volin MV, Mandelin AM II, Agrawal H, Matsui M, Yoshimoto T, Shahrara S (2011) Local expression of interleukin-27 ameliorates collagen-induced arthritis. Arthritis Rheum 63(8):2289\u20132298","journal-title":"Arthritis Rheum"},{"issue":"2","key":"9477_CR161","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0092-8674(94)90337-9","volume":"76","author":"TA Springer","year":"1994","unstructured":"Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76(2):301\u2013314","journal-title":"Cell"},{"issue":"5084","key":"9477_CR162","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1126\/science.1439808","volume":"258","author":"LA Lasky","year":"1992","unstructured":"Lasky LA (1992) Selectins: interpreters of cell-specific carbohydrate information during inflammation. Science 258(5084):964\u2013969","journal-title":"Science"},{"issue":"4895","key":"9477_CR163","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.2466335","volume":"243","author":"MP Bevilacqua","year":"1989","unstructured":"Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B (1989) Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243(4895):1160\u20131165","journal-title":"Science"},{"issue":"2","key":"9477_CR164","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s00228-013-1605-6","volume":"70","author":"N Maruotti","year":"2014","unstructured":"Maruotti N, Cantatore FP, Ribatti D (2014) Putative effects of potentially anti-angiogenic drugs in rheumatic diseases. Eur J Clin Pharmacol 70(2):135\u2013140","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"9477_CR165","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/art.20001","volume":"50","author":"E Lubberts","year":"2004","unstructured":"Lubberts E, Koenders MI, Oppers-Walgreen B, van den Bersselaar L, Coenen-de Roo CJ, Joosten LA, van den Berg WB (2004) Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 50(2):650\u2013659","journal-title":"Arthritis Rheum"},{"issue":"6","key":"9477_CR166","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1136\/annrheumdis-2012-201601","volume":"72","author":"MC Genovese","year":"2013","unstructured":"Genovese MC, Durez P, Richards HB, Supronik J, Dokoupilova E, Mazurov V, Aelion JA, Lee SH, Codding CE, Kellner H, Ikawa T, Hugot S, Mpofu S (2013) Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study. Ann Rheum Dis 72(6):863\u2013869","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"9477_CR167","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/art.38617","volume":"66","author":"MC Genovese","year":"2014","unstructured":"Genovese MC, Greenwald M, Cho CS, Berman A, Jin L, Cameron GS, Benichou O, Xie L, Braun D, Berclaz PY, Banerjee S (2014) A phase II randomized study of subcutaneous ixekizumab, an anti-interleukin-17 monoclonal antibody, in rheumatoid arthritis patients who were naive to biologic agents or had an inadequate response to tumor necrosis factor inhibitors. Arthritis Rheumatol 66(7):1693\u20131704","journal-title":"Arthritis Rheumatol"},{"issue":"24","key":"9477_CR168","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1315231","volume":"370","author":"PJ Mease","year":"2014","unstructured":"Mease PJ, Genovese MC, Greenwald MW, Ritchlin CT, Beaulieu AD, Deodhar A, Newmark R, Feng J, Erondu N, Nirula A (2014) Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis. N Engl J Med 370(24):2295\u20132306","journal-title":"N Engl J Med"},{"issue":"2","key":"9477_CR169","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00011-009-0072-0","volume":"59","author":"HP Yao","year":"2010","unstructured":"Yao HP, Qian Y, Shao XT, Xu ZR, Cheng LF, Feng L, Wu NP, Yang YM (2010) Construction of a recombinant adenovirus vector expressing IL-18BP\/IL-4 fusion gene and the anti-inflammatory effect induced by this gene on lipopolysaccharide-stimulated synovial fibroblasts. Inflamm Res 59(2):97\u2013104","journal-title":"Inflamm Res"},{"issue":"10","key":"9477_CR170","doi-asserted-by":"publisher","first-page":"867","DOI":"10.5414\/CP202087","volume":"52","author":"P Mistry","year":"2014","unstructured":"Mistry P, Reid J, Pouliquen I, McHugh S, Abberley L, DeWall S, Taylor A, Tong X, Rocha Del Cura M, McKie E (2014) Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose antiinterleukin-18 mAb GSK1070806 in healthy and obese subjects. Int J Clin Pharmacol Ther 52(10):867\u2013879","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"2","key":"9477_CR171","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF03191127","volume":"31","author":"PP Tak","year":"2006","unstructured":"Tak PP, Bacchi M, Bertolino M (2006) Pharmacokinetics of IL-18 binding protein in healthy volunteers and subjects with rheumatoid arthritis or plaque psoriasis. Eur J Drug Metab Pharmacokinet 31(2):109\u2013116","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"3","key":"9477_CR172","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1517\/14728220903551304","volume":"14","author":"D Greven","year":"2010","unstructured":"Greven D, Leng L, Bucala R (2010) Autoimmune diseases: MIF as a therapeutic target. Expert Opin Ther Targets 14(3):253\u2013264","journal-title":"Expert Opin Ther Targets"},{"issue":"2","key":"9477_CR173","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1021\/jm801100v","volume":"52","author":"Z Cournia","year":"2009","unstructured":"Cournia Z, Leng L, Gandavadi S, Du X, Bucala R, Jorgensen WL (2009) Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening. J Med Chem 52(2):416\u2013424","journal-title":"J Med Chem"},{"issue":"4","key":"9477_CR174","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1159\/000354229","volume":"40","author":"S Fruehauf","year":"2013","unstructured":"Fruehauf S (2013) Current clinical indications for plerixafor. Transfus Med Hemother 40(4):246\u2013250","journal-title":"Transfus Med Hemother"},{"issue":"2","key":"9477_CR175","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1158\/1078-0432.CCR-12-2333","volume":"19","author":"MR Kuhne","year":"2013","unstructured":"Kuhne MR, Mulvey T, Belanger B, Chen S, Pan C, Chong C, Cao F, Niekro W, Kempe T, Henning KA, Cohen LJ, Korman AJ, Cardarelli PM (2013) BMS-936564\/MDX-1338: a fully human anti-CXCR4 antibody induces apoptosis in vitro and shows antitumor activity in vivo in hematologic malignancies. Clin Cancer Res 19(2):357\u2013366","journal-title":"Clin Cancer Res"},{"issue":"10","key":"9477_CR176","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1158\/1535-7163.MCT-10-0213","volume":"9","author":"A Coxon","year":"2010","unstructured":"Coxon A, Bready J, Min H, Kaufman S, Leal J, Yu D, Lee TA, Sun JR, Estrada J, Bolon B, McCabe J, Wang L, Rex K, Caenepeel S, Hughes P, Cordover D, Kim H, Han SJ, Michaels ML, Hsu E, Shimamoto G, Cattley R, Hurh E, Nguyen L, Wang SX, Ndifor A, Hayward IJ, Falcon BL, McDonald DM, Li L, Boone T, Kendall R, Radinsky R, Oliner JD (2010) Context-dependent role of angiopoietin-1 inhibition in the suppression of angiogenesis and tumor growth: implications for AMG 386, an angiopoietin-1\/2-neutralizing peptibody. Mol Cancer Ther 9(10):2641\u20132651","journal-title":"Mol Cancer Ther"},{"issue":"1\u20132","key":"9477_CR177","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jim.2013.07.010","volume":"396","author":"DK Weeraratne","year":"2013","unstructured":"Weeraratne DK, Lofgren J, Dinnogen S, Swanson SJ, Zhong ZD (2013) Development of a biosensor-based immunogenicity assay capable of blocking soluble drug target interference. J Immunol Methods 396(1\u20132):44\u201355","journal-title":"J Immunol Methods"},{"issue":"4","key":"9477_CR178","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1186\/ar4265","volume":"15","author":"YS Hah","year":"2013","unstructured":"Hah YS, Koh YJ, Lim HS, Kim HO, Cheon YH, Noh HS, Jang KY, Lee SY, Lee GM, Koh GY, Lee SI (2013) Double-antiangiogenic protein DAAP targeting vascular endothelial growth factor A and angiopoietins attenuates collagen-induced arthritis. Arthritis Res Ther 15(4):R85","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"9477_CR179","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2165\/11318390-000000000-00000","volume":"70","author":"G Dorman","year":"2010","unstructured":"Dorman G, Cseh S, Hajdu I, Barna L, Konya D, Kupai K, Kovacs L, Ferdinandy P (2010) Matrix metalloproteinase inhibitors: a critical appraisal of design principles and proposed therapeutic utility. Drugs 70(8):949\u2013964","journal-title":"Drugs"},{"issue":"11","key":"9477_CR180","first-page":"1014","volume":"7","author":"MM Thabet","year":"2006","unstructured":"Thabet MM, Huizinga TW (2006) Drug evaluation: apratastat, a novel TACE\/MMP inhibitor for rheumatoid arthritis. Curr Opin Investig Drugs 7(11):1014\u20131019","journal-title":"Curr Opin Investig Drugs"},{"issue":"23","key":"9477_CR181","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1001\/jama.290.23.3073","volume":"290","author":"KB Gordon","year":"2003","unstructured":"Gordon KB, Papp KA, Hamilton TK, Walicke PA, Dummer W, Li N, Bresnahan BW, Menter A (2003) Efalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trial. JAMA 290(23):3073\u20133080","journal-title":"JAMA"},{"issue":"6","key":"9477_CR182","first-page":"712","volume":"13","author":"EF Prater","year":"2014","unstructured":"Prater EF, Day A, Patel M, Menter A (2014) A retrospective analysis of 72 patients on prior efalizumab subsequent to the time of voluntary market withdrawal in 2009. J Drugs Dermatol 13(6):712\u2013718","journal-title":"J Drugs Dermatol"},{"issue":"4","key":"9477_CR183","first-page":"442","volume":"3","author":"R Jones","year":"2000","unstructured":"Jones R (2000) Rovelizumab (ICOS Corp). IDrugs Investig Drugs J 3(4):442\u2013446","journal-title":"IDrugs Investig Drugs J"},{"issue":"7","key":"9477_CR184","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1002\/art.1780370703","volume":"37","author":"AF Kavanaugh","year":"1994","unstructured":"Kavanaugh AF, Davis LS, Nichols LA, Norris SH, Rothlein R, Scharschmidt LA, Lipsky PE (1994) Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. Arthritis Rheum 37(7):992\u2013999","journal-title":"Arthritis Rheum"},{"issue":"8","key":"9477_CR185","first-page":"1338","volume":"23","author":"AF Kavanaugh","year":"1996","unstructured":"Kavanaugh AF, Davis LS, Jain RI, Nichols LA, Norris SH, Lipsky PE (1996) A phase I\/II open label study of the safety and efficacy of an anti-ICAM-1 (intercellular adhesion molecule-1; CD54) monoclonal antibody in early rheumatoid arthritis. J Rheumatol 23(8):1338\u20131344","journal-title":"J Rheumatol"},{"issue":"5","key":"9477_CR186","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/art.1780400511","volume":"40","author":"AF Kavanaugh","year":"1997","unstructured":"Kavanaugh AF, Schulze-Koops H, Davis LS, Lipsky PE (1997) Repeat treatment of rheumatoid arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody. Arthritis Rheum 40(5):849\u2013853","journal-title":"Arthritis Rheum"},{"key":"9477_CR187","first-page":"CD007621","volume":"10","author":"E Pucci","year":"2011","unstructured":"Pucci E, Giuliani G, Solari A, Simi S, Minozzi S, Di Pietrantonj C, Galea I (2011) Natalizumab for relapsing remitting multiple sclerosis. Cochrane Database Syst Rev 10:CD007621","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"9477_CR188","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2141.2011.08864.x","volume":"155","author":"K Podar","year":"2011","unstructured":"Podar K, Zimmerhackl A, Fulciniti M, Tonon G, Hainz U, Tai YT, Vallet S, Halama N, Jager D, Olson DL, Sattler M, Chauhan D, Anderson KC (2011) The selective adhesion molecule inhibitor Natalizumab decreases multiple myeloma cell growth in the bone marrow microenvironment: therapeutic implications. Br J Haematol 155(4):438\u2013448","journal-title":"Br J Haematol"},{"key":"9477_CR189","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pharmthera.2014.11.008","volume":"147","author":"I Mitroulis","year":"2015","unstructured":"Mitroulis I, Alexaki VI, Kourtzelis I, Ziogas A, Hajishengallis G, Chavakis T (2015) Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol Ther 147:123\u2013135","journal-title":"Pharmacol Ther"}],"container-title":["Angiogenesis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-015-9477-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10456-015-9477-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-015-9477-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10456-015-9477-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T14:12:09Z","timestamp":1748527929000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10456-015-9477-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,22]]},"references-count":189,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["9477"],"URL":"https:\/\/doi.org\/10.1007\/s10456-015-9477-2","relation":{},"ISSN":["0969-6970","1573-7209"],"issn-type":[{"value":"0969-6970","type":"print"},{"value":"1573-7209","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,22]]},"assertion":[{"value":"5 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}